Quality of Pharmaceuticals and Outsourcing / Understanding the Inherent Risks to the Patient – Part 2
Journal
Pharmind
ISSN
0031-711X
Type
journal article
Date Issued
2022
Author(s)
Abstract (De)
This article provides a comprehensive overview of outsourcing in pharmaceutical manufacturing. It discusses the motivation of the industry to leverage outsourcing advanteages, especially to China and India, but also related disadvantages. Key facts about quality issues related to outsourcing are outlined with examples. The increasing complexity of pharmaceutical manufacturing supply chains an an aggravated oversight of suppliers with the loose of control are just one explanation for that. Furthermore, the article describes how outsourcing impacts quality risks and draws on examples from the past. To mitigate these, practical advice for supplier due diligence, contractor selection and assessment process, and how to achieve operational excellence in outsourcing and internal manufacturing is drawn from a cost and risk perspective.
Language
English
HSG Classification
contribution to scientific community
Refereed
No
Publisher
Editio-Cantor-Verl. für Medizin und Naturwiss.
Publisher place
Aulendorf (Germany)
Volume
84
Number
5
Start page
572
End page
585
Pages
14
Subject(s)
Division(s)
Contact Email Address
thomas.friedli@unisg.ch
References
First published in Friedli et al: 21c Quality Management in the Pharmaceutical Industry, The Journey from Compliance to Excellence, ECV 2018, p. 49-83.
Eprints ID
266487